RETATRUTIDE - AN OVERVIEW

8 trials have investigated the influence of GLP-1R agonists on MACE in T2DM individuals to date, of which 5 showed favorable results and three revealed neutral cardiovascular Positive aspects. A more recent demo also demonstrated cardioprotective Gains in clients living with being overweight but without having T2DM.System of Action and Performance.